CTC Bio Inc. logo

CTC Bio Inc. (060590)

Market Closed
11 Aug, 05:22
KRX SM KRX SM
3,350. 00
+70
+2.1341%
78.3B Market Cap
- P/E Ratio
23.06% Div Yield
111,376 Volume
- Eps
3,280
Previous Close
Add Transaction
Day Range
3,245 3,435
Year Range
2,570 7,680
Want to track 060590 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

060590 closed today higher at ₩3,350, an increase of 2.1341% from yesterday's close, completing a monthly increase of 13.9456% or ₩410. Over the past 12 months, 060590 stock lost -28.4952%.
060590 pays dividends to its shareholders, with the most recent payment made on Mar 23, 2022.
CTC Bio Inc. has completed 3 stock splits, with the recent split occurring on Apr 22, 2013.
The company's stock is traded on one exchange.

060590 Chart

People also search for

Fine M-Tec Co., Ltd.
8,930
-2.5109%
Genexine Co., Ltd.
2,755
+1.2868%
TiumBio Co., Ltd.
4,950
-1.5905%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,160
0%

CTC Bio Inc. (060590) FAQ

What is the stock price today?

The current price is ₩3,350.00.

On which exchange is it traded?

CTC Bio Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 060590.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 23.06%.

What is its market cap?

As of today, the market cap is 78.3B.

Has CTC Bio Inc. ever had a stock split?

CTC Bio Inc. had 3 splits and the recent split was on Apr 22, 2013.

CTC Bio Inc. Profile

Biotechnology Industry
Healthcare Sector
Mr. Sun Cho Chang CEO
KRX SM Exchange
- ISIN
South Korea Country
248 Employees
- Last Dividend
22 Apr 2013 Last Split
- IPO Date

Overview

CTCBIO Inc. is a globally recognized entity in the pharmaceutical sector, originating from South Korea and extending its services and products internationally. Founded in 1993, the company has carved a niche for itself in both animal and human pharmaceuticals, leveraging extensive scientific research and innovation to drive its product development. Headquartered in Hwaseong, South Korea, CTCBIO Inc.'s strategic focus encompasses a wide array of health-related areas, from disease management and prevention to health enhancement through functional foods. Their commitment to excellence is reflected not only in their comprehensive product lineup but also in their cutting-edge solutions like the CTC covid-19 IgM/IgG combo test, demonstrating their agility in responding to global health crises.

Products and Services

  • Animal and Human Pharmaceuticals:

    CTCBIO offers a diverse pharmaceutical portfolio for both human and veterinary use, including treatments for cardiovascular diseases, gastrointestinal disorders, osteoporosis, and infections among others. This segment ensures the availability of quality medicines to enhance health and manage diseases effectively.

  • Feed Additives and Ingredients:

    Understanding the critical role of nutrition in animal health, CTCBIO provides a range of feed additives and ingredients. These products aim to improve the nutritional value of animal feed, thereby promoting healthier and more productive livestock.

  • Functional Food Products:

    With a growing consumer focus on wellness, CTCBIO’s functional food products are designed to offer health benefits beyond basic nutrition. These include foods enriched with active ingredients that contribute to better health, aid in the prevention of disease, or support the management of chronic conditions.

  • Pharmaceutical Ingredients and Drug Formulation Components:

    The company also specializes in the provision of active pharmaceutical ingredients (APIs), alongside excipients such as coating bases, diluting agents, bonding agents, and lubricants that are pivotal in drug formulation.

  • CTC covid-19 IgM/IgG Combo Test:

    In response to the global pandemic, CTCBIO developed the CTC covid-19 IgM/IgG combo test, a rapid antibody test kit that provides quick results for COVID-19 testing, showcasing the company's commitment to contributing towards global health security.

  • Animal Health Products:

    Beyond pharmaceuticals for disease treatment, CTCBIO offers a variety of products aimed at enhancing animal health. This includes physiological activators, functional enhancers, and disinfectants, all designed to ensure the well-being of animals.

Contact Information

Address: Tower A, 901
Phone: 82 1 661 8800